Italia markets closed

BMY Jun 2024 37.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,05000,0000 (0,00%)
In data: 03:23PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,0500
Aperto0,0500
Denaro0,0200
Lettera0,2400
Prezzo d'esercizio37,00
Scadenza2024-06-21
Min-Max giorno0,0500 - 0,0500
Contratto - Min-MaxN/D
Volume1
Open Interest161
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri